| DM (n = 14) | ASS (n = 7) | P value |
MMT-8 | 80 (80 - 80) | 80 (80 - 80) | >0.999 |
MYOACT (0 - 60) | 0.0 (0.0 - 0.0) | 0.0 (0.0 - 0.0) | 0.336 |
Physician’s VAS (0 - 10 cm) | 0.0 (0.0 - 0.0) | 0.0 (0.0 - 0.0) | >0.999 |
Patient’s VAS (0 - 10 cm) | 0.0 (0.0 - 0.2) | 2.5 (2.4 - 4.2) | 0.155 |
HAQ (0.00 - 3.00) | 0.00 (0.00 - 0.20) | 0.5 (0.0 - 1.00) | 0.289 |
CPK (U/L) | 107 (91 - 180) | 162 (92 - 253) | 0.287 |
AST (U/L) | 10 (11 - 18) | 13 (11 - 28) | 0.689 |
ALT (U/L) | 12 (11 - 23) | 12 (20 - 28) | 0.799 |
LDH (U/L) | 202 (170 - 209) | 210 (210 - 304) | 0.335 |
Prednisone |
|
|
|
Current use | 4 (28.4) | 0 | - |
Current dose (mg/day) | 2.5 (0.0 - 5.0) | - | - |
IS/IM/Immunobiological | 12 (85.5) | 5 (71.4) | - |
Azatioprine | 5 (35.7) | 2 (28.5) | 0.799 |
Methotrexate | 2 (14.2) | 1 (14.2) | 0.636 |
Mycophenolate of mofetil | 3 (21.4) | 2 (28.5) | 0.799 |
Lefunomide | 1 (7.1) | 0 | - |
Rituximab | 1 (7.1) | 0 | - |
Other drugs | 6 (42.8) | 3 (42.8) | >0.999 |
Beta blocker | 3 (21.4) | 0 | - |
Calcium channel blocker | 3 (21.4) | 3 (42.8) | 0.630 |